GAAD

Effective Early Detection
of
Hepatocellular Carcinoma (HCC)

What is PIVKA-II & GAAD Score?

Early-stage liver cancer often does not present symptoms. Therefore, early screening is essential.

A newer biomarker PIVKA-II has been shown to improve the detection of early-stage liver cancer compared to AFP alone. Patients with early-stage liver cancer may still have normal blood results.

For this reason, the GAAD algorithm has been developed to enhance screening performance, providing earlier and more accurate detection.

Who Should Be Screened?

✅ Patients with liver cirrhosis

✅ Chronic hepatitis B or C infection

✅ Fatty liver disease and Elevated liver enzymes

✅ Men > 40 years and Women > 50 years

✅ Family history of liver cancer

✅  Regular alcohol consumption

Why Choose Our Clinic?

  • Simple and convenient blood test.
  • Accurate results with quality laboratory.
  • Fast turnaround time within 2-3 hours.

Early Detection
Saves Lives

Don't wait for symptoms to appear

Screen,
Act,
Live healthy!